Portal hypertension is an absolute contraindication, as these patients are not surgical candidates and are at higher risk of significant complications from<unk> . Additionally, complete lobar portal vein occlusion of either lobe would preclude expected increases in FLR from<unk>  due to already existing diversion of portal flow. Patients with extrahepatic metastatic disease are also not candidates for resection, and therefore<unk>  is contraindicated. In the past patients with bi-lobar disease were not considered for<unk> , however now there may be a role of<unk>  in combination with a two-stage hepatectomy. Additionally, patients who have an inadequate predicted FLR post<unk>  should not be considered. Other contraindications include any conditions that make a patient unfit for surgery or intervention (poor cardiopulmonary status, sepsis, kidney failure, etc).
Portal vein embolization
Hepatic artery embolization
Hepatic artery thrombosis
Portal vein thrombosis
Thrombectomy
Fibrinolysis syndrome
Percutaneous hepatic perfusion
Embolization